Blood testing is the analysis of blood samples. It is used in healthcare to detect mineral contents in blood, diseases and disease-causing infections, and signs of drug abuse. It helps physicians to understand the biochemical and physiological state of the blood, pharmaceutical drug effectiveness, and organ functioning. For blood testing, blood is either taken from a vein in the arm with the help of a syringe or through a finger prick with the help of a needle.
Technavio’s analysts forecast the global blood testing market to grow at a CAGR of 2.82% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global blood testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of blood testing equipment, which includes instruments, reagents, and consumables.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio’s report, Global Blood Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors • Abbott Laboratories • Bio-Rad Laboratories • F. Hoffmann La Roche • Siemens Healthineers
Other prominent vendors • bioMerieux • Cardinal Health • Cepheid • Danaher • Novartis • Thermo Fisher Scientific • Trinity Biotech • Trividia Health
Market driver • High demand for RDTs • For a full, detailed list, view our report
Market challenge • Lack of trained professionals • For a full, detailed list, view our report
Market trend • Thriving demand for POCT • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
The South and Central America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable...
609 pages •
By Global Industry Analysts
• May 2021
Global Diabetes Diagnostics Market to Reach $42.4 Billion by 2026
Diabetes diagnostics systems are used to measure blood glucose levels or blood sugar levels, which indicates whether or not a person is suffering from diabetes. Demand for diabetes diagnostics devices and systems...
The global medical device and diagnostics contract research organization market is expected to reach US$ 20,336.08 million in 2028 from US$ 12,314.65 million in 2021. The market is estimated to grow with a CAGR of 7.4% from 2021 to 2028. Key factors driving the market such as increasing number of clinical trials worldwide and rise in adoption...
The PCR for respiratory infection diagnostics market was valued at US$ 8279.32 million by 2028 from US$ 4146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. Driving factors of PCR for respiratory infection diagnostics market are globally factors such as the increasing Burden of Chronic Respiratory Diseases...
The veterinary diagnostics market is expected to reach USD 3.9 billion by 2026 from an estimated USD 2.5 billion in 2021, at a CAGR of 9.4%. Market growth can largely be attributed to the growth in the companion animal population, increasing incidence of transboundary and zoonotic diseases, rising demand for animal-derived food products, rising...
The global infectious disease diagnostics market size is projected to reach USD 39.8billion by 2026 from USD 28.1billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift...
241 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Home Testing Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...
The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 9.95% during 2020-2028. The factors such as increasing prevalence of irritable bowel syndrome (IBS) diseases and rising research & development activities...
Executive Summary The Global Blood Transfusion Diagnostics Market was valued at USD 2192.55 Million in the year 2020. Rising prevalence of chronic diseases and increasing demand for donor screening are some of the major factors driving the market growth. Rising cases of road accidents, trauma, and surgeries have also led...
The Middle East and Africa irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 156.79 million by 2028 from US$ 117.32 million in 2020; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable...
Digestive System Disorder
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.